🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether NNZ-2566 is safe and well...
Status
Completed
Location
University of Alabama
Start Date
2016-03
Trial ID
NCT02715115
The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-01-12
Trial ID
NCT03004404
The goal of this clinical trial is to learn if a probiotic formulation cons...
Status
Recruiting
Location
ALYATEC clinical center
Start Date
2025-09-01
Trial ID
NCT07157462
The purpose of this study is to determine whether Forlax® is more effective...
Status
Completed
Location
Ramathibodi Hospital, Mahidol University,
Start Date
2005-04
Trial ID
NCT00255372
Treatments Being Tested
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI...
Status
Terminated
Location
Multiple Locations
Start Date
2011-05
Trial ID
NCT01348165
This will be a two-part study in healthy adults. Part A is a phase 1, non-r...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05
Trial ID
NCT01848340
Treatments Being Tested
To assess the bronchodilation of three doses of formoterol fumarate (6 μg, ...
Status
Completed
Location
Research Site
Start Date
2016-06-30
Trial ID
NCT02796651
This is a Phase 1, double-blind (Sponsor-open), placebo-controlled, randomi...
Status
Completed
Location
High Point Clinical Trials Center
Start Date
2022-07-07
Trial ID
NCT05462132
Treatments Being Tested
The purpose of this study was to evaluate safety and efficacy of the combin...
Status
Terminated
Location
California Cancer Associates for Research and Excellence
Start Date
2017-02-17
Trial ID
NCT02967692
Treatments Being Tested
To investigate safety, tolerability, and pharmacokinetics of multiple risin...
Status
Completed
Location
1305.2.1 Boehringer Ingelheim Investigational Site
Start Date
2013-04
Trial ID
NCT01835899
Treatments Being Tested